BRAF and melanoma: Notably, mucosal melanoma exhibits distinct molecular characteristics compared to its cutaneous counterpart, such as a lower BRAF mutation rate and a higher prevalence of NF1 mutations, which restrict the applicability of targeted therapies (17).